Effect of Early Treatment with Ivermectin among Patients with Covid-19

Ivermectin as empiric treatment for Strongyloides in patients with COVID-19, CCDR 47(7/8)

IVERMECTIN REPROPOSING FOR COVID-19 TREATMENT OUTPATIENTS IN MILD STAGE IN PRIMARY HEALTH CARE CENTERS

Ivermectin demand drives some to pro-Trump telemedicine website

Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial

Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients, Virology Journal

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes - ScienceDirect

NIH ends COVID treatment guidelines : Shots - Health News : NPR

Bankrupt FTX Gave $18.2M to Early COVID-19 Researchers Who Cast Doubt on Ivermectin and Hydroxychloroquine - The Maine Wire

Eric Topol on X: Ivermectin: the largest randomized, double-blind trial yet conducted, with early treatment, indicates there is no difference compared with placebo. It doesn't work. Period. just published @NEJM

Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype, BMC Infectious Diseases

Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)